I. Goldenberg

Circadian variation and seasonal distribution of implantable defibrillator detected new onset atrial fibrillation

W. Zareba, I. Goldenberg, S. McNitt, 2020, Pacing and clinical electrophysiology : PACE.

Competing risk analysis of ventricular arrhythmia events in heart failure patients with moderately compromised renal dysfunction.

W. Zareba, S. McNitt, M. Aktas, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction

T. Mor, R. Beinart, R. Rosso, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Anemia and the Risk of Life-threatening Ventricular Tachyarrhythmias from the Israeli Implantable Cardioverter Defibrillator Registry.

M. Glikson, J. Schliamser, A. Barsheshet, 2017, The American journal of cardiology.

Subcutaneous ICD combined with VT ablation for the secondary prevention of sudden cardiac death: pilot data from the prospective multinational SICD-VTAbl study

P. Friedman, P. Maury, E. Nof, 2021, European Heart Journal.

Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator

W. Zareba, O. Wazni, I. Goldenberg, 2023, medRxiv.

Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator

W. Zareba, O. Wazni, I. Goldenberg, 2023, Circulation.

Sex-Differences in Arrhythmic Burden with the Wearable Cardioverter Defibrillator.

A. Russo, B. Assmus, S. McNitt, 2020, Heart rhythm.

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease

W. Zareba, C. Schuger, I. Goldenberg, 2023, Frontiers in cardiovascular medicine.

Risk Stratification for Ventricular Tachyarrhythmia in Patients with Non-Ischemic Cardiomyopathy

I. Goldenberg, A. Md, D. T. Md, 2023, medRxiv.

Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients.

W. Zareba, I. Goldenberg, S. McNitt, 2023, JACC. Clinical electrophysiology.

Risk Prediction in Male Adolescents With Congenital Long QT Syndrome: Implications for Sex‐Specific Risk Stratification in Potassium Channel‐Mediated Long QT Syndrome

D. Arking, N. Sotoodehnia, S. McNitt, 2024, Journal of the American Heart Association.

Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival

V. Guetta, R. Beinart, S. Tiosano, 2023, Journal of clinical medicine.

Anemia and the Risk of Life-threatening Ventricular Tachyarrhythmias from the Israeli Implantable Cardioverter Defibrillator Registry.

M. Glikson, J. Schliamser, A. Barsheshet, 2017, The American journal of cardiology.